日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer

阐明循环肿瘤DNA在早期结肠癌患者管理中的预后和预测价值

Yanes, Rami; Saridogan, Turcin; Gorantla, Vikram; Overacre, Abigail; Hsieh, Ronan W; Celebrezze, James; Magge, Tara; Singhi, Meghana; Saeed, Anwaar; Zureikat, Amer H; Dasari, Arvind N; Sahin, Ibrahim Halil

Predictive biomarkers for immune checkpoint inhibition for patients with colorectal cancer: a comprehensive review

结直肠癌患者免疫检查点抑制剂治疗的预测性生物标志物:一项综合综述

Sahin, Ibrahim Halil; Saridogan, Turcin; Kim, Richard

Investigating the WNT and TGF-beta pathways alterations and tumor mutant burden in young-onset colorectal cancer

研究WNT和TGF-β通路改变以及年轻发病型结直肠癌的肿瘤突变负荷

Ferrell, Morgan; Guven, Deniz Can; Gomez, Cyndi Gonzalez; Nasrollahi, Elham; Giza, Richard; Cheng, Svea; Syed, Masood Pasha; Magge, Tara; Singhi, Aatur; Saeed, Anwaar; Saridogan, Turcin; Sahin, Ibrahim Halil

Dispersed DNA variants underlie hearing loss in South Florida's minority population

南佛罗里达州少数族裔人群听力损失的根本原因在于分散的DNA变异。

Peart, LéShon; Gonzalez, Joanna; Morel Swols, Dayna; Duman, Duygu; Saridogan, Turcin; Ramzan, Memoona; Zafeer, Mohammad Faraz; Liu, Xue Zhong; Eshraghi, Adrien A; Hoffer, Michael E; Angeli, Simon I; Bademci, Guney; Blanton, Susan; Smith, Carson; Telischi, Fred F; Tekin, Mustafa

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

不可逆成纤维细胞生长因子受体抑制剂富巴替尼在FGFR改变的乳腺癌中的疗效

Turcin Saridogan ,Argun Akcakanat ,Ming Zhao ,Kurt W Evans ,Erkan Yuca ,Stephen Scott ,Bryce P Kirby ,Xiaofeng Zheng ,Min Jin Ha ,Huiqin Chen ,Patrick K S Ng ,Timothy P DiPeri ,Gordon B Mills ,Jordi Rodon Ahnert ,Senthil Damodaran ,Funda Meric-Bernstam

Systemic Therapy for Patients With Pancreatic Cancer: Current Approaches and Opportunities for Novel Avenues Toward Precision Medicine

胰腺癌患者的系统性治疗:当前方法及迈向精准医学的新途径

Ayasun, Ruveyda; Saridogan, Turcin; Gaber, Ola; Sahin, Ibrahim Halil

Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer

氧化磷酸化是化疗耐药性三阴性乳腺癌的代谢弱点

Kurt W Evans, Erkan Yuca, Stephen S Scott, Ming Zhao, Natalia Paez Arango, Christian X Cruz Pico, Turcin Saridogan, Maryam Shariati, Caleb A Class, Christopher A Bristow, Christopher P Vellano, Xiaofeng Zheng, Ana Maria Gonzalez-Angulo, Xiaoping Su, Coya Tapia, Ken Chen, Argun Akcakanat, Bora Lim, D

Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer

在 HER2 阳性癌症模型中将 Neratinib 与 CDK4/6、mTOR 和 MEK 抑制剂联合使用

Ming Zhao #, Stephen Scott #, Kurt W Evans, Erkan Yuca, Turcin Saridogan, Xiaofeng Zheng, Heping Wang, Anil Korkut, Christian X Cruz Pico, Mehmet Demirhan, Bryce Kirby, Scott Kopetz, Irmina Diala, Alshad S Lalani, Sarina Piha-Paul, Funda Meric-Bernstam

Adenoidal bacterial biofilm in pediatric rhinosinusitis

儿童鼻窦炎中的腺样体细菌生物膜

Bugari, Radmila Anca; Başchir, Aristide Sorin; Turcin, Luminiţa Adela; Chioreanu, Alexandru; Mihali, Ciprian Valentin; Ilie, Adrian Cosmin; Jompan, Afilon; Bălăşoiu, Maria